Vanguard Group’s Hoth Therapeutics HOTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.4K | Hold |
38,804
| – | – | ﹤0.01% | 4205 |
|
|
2025
Q1 | $38.8K | Hold |
38,804
| – | – | ﹤0.01% | 4208 |
|
|
2024
Q4 | $29K | Hold |
38,804
| – | – | ﹤0.01% | 4240 |
|
|
2024
Q3 | $34.1K | Hold |
38,804
| – | – | ﹤0.01% | 4270 |
|
|
2024
Q2 | $35.3K | Hold |
38,804
| – | – | ﹤0.01% | 4315 |
|
|
2024
Q1 | $59K | Hold |
38,804
| – | – | ﹤0.01% | 4298 |
|
|
2023
Q4 | $55.9K | Hold |
38,804
| – | – | ﹤0.01% | 4360 |
|
|
2023
Q3 | $59K | Buy |
38,804
+26,572
| +217% | +$40.4K | ﹤0.01% | 4391 |
|
|
2023
Q2 | $36.7K | Buy |
12,232
+1,795
| +17% | +$5.39K | ﹤0.01% | 4489 |
|
|
2023
Q1 | $21.5K | Buy |
+10,437
| New | +$21.5K | ﹤0.01% | 4526 |
|
|
2022
Q4 | – | Sell |
-942,305
| Closed | -$328K | – | 4541 |
|
|
2022
Q3 | $328K | Buy |
942,305
+177,659
| +23% | +$61.8K | ﹤0.01% | 4329 |
|
|
2022
Q2 | $321K | Hold |
764,646
| – | – | ﹤0.01% | 4393 |
|
|
2022
Q1 | $529K | Buy |
764,646
+54,600
| +8% | +$37.8K | ﹤0.01% | 4389 |
|
|
2021
Q4 | $469K | Hold |
710,046
| – | – | ﹤0.01% | 4441 |
|
|
2021
Q3 | $845K | Buy |
710,046
+3,851
| +0.5% | +$4.58K | ﹤0.01% | 4282 |
|
|
2021
Q2 | $1.13M | Buy |
706,195
+612,118
| +651% | +$979K | ﹤0.01% | 4124 |
|
|
2021
Q1 | $185K | Buy |
94,077
+44,390
| +89% | +$87.3K | ﹤0.01% | 4269 |
|
|
2020
Q4 | $118K | Hold |
49,687
| – | – | ﹤0.01% | 4130 |
|
|
2020
Q3 | $98K | Hold |
49,687
| – | – | ﹤0.01% | 4016 |
|
|
2020
Q2 | $128K | Buy |
49,687
+18,266
| +58% | +$47.1K | ﹤0.01% | 3969 |
|
|
2020
Q1 | $96K | Buy |
31,421
+200
| +0.6% | +$611 | ﹤0.01% | 3950 |
|
|
2019
Q4 | $193K | Buy |
+31,221
| New | +$193K | ﹤0.01% | 3944 |
|